Atlas Trials

Pioglitazone as an Adjunct to Cognitive-Behavioral Therapy for Cocaine Relapse Prevention

Clinical trial NCT04843046 · COMPLETED

Trial details

NCT number
NCT04843046
Sponsor
The University of Texas Health Science Center, Houston
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Cocaine Use Disorder
Start date
2021-08-23
Primary completion
2025-09-26
Enrollment
61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.